Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Peptide Therapeutics
- Importance of Peptides
- Peptide Synthesis
- Trends in Peptide Therapeutics
Chapter 3 Market Dynamics
- Market Drivers
- Overview
- Rising Incidence of Chronic Diseases
- Developments in Peptide Drug Delivery
- Increase in Biotech Spending
- Increase in Infectious and Chronic Diseases
- Market Restraints
- Issues in Sustainability in Synthetic Peptide Production
- Market Opportunities
- Oral Peptide Therapeutics
- Opportunities in Emerging Nations
Chapter 4 Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
- Introduction
- Advances in SPPS in Aqueous Media
- Chemical Synthesis
- Peptide Drug Delivery
- Examples of New Developments, by Company
- Nissan Chemical Corp.
- Gyros Protein Technologies AB
Chapter 5 Market Analysis, by Segment
- Segmentation Breakdown
- Peptide Synthesis by Peptide Type
- Global Market for Peptide Synthesis, by Peptide Type
- Synthetic Peptides
- Antimicrobial Peptides
- Hormonal Peptides
- Bioactive Peptides
- Collagen Peptides
- Other Products
- Global Market for Peptide Synthesis, by Application
- Peptide Therapeutics
- Cosmetics
- Nutraceuticals
- Other Types of Applications
- Peptide Synthesis by Synthesis Type
- Global Market for Peptide Synthesis by Synthesis Type
- Solid-phase
- Solution-phase
- Hybrid-phase
- Peptide Synthesis by Region
- Regional Breakdown
- Global Market for Peptide Synthesis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Landscape
- Top Players
- Strategic Analysis
- M&A Analysis
- M&A Deals in 2020-2023
- Flourishing Biotech Startups (2023)
- Neumora Therapeutics Inc.
- Altos Labs
- Affini-T Therapeutics
- Capstan Therapeutics
- Septerna Inc.
Chapter 7 Sustainability in the Peptide Synthesis Industry: An ESG Perspective
- Importance of ESG among Peptide Therapeutics Manufacturers
- ESG Practices of Peptide Therapeutics Manufacturers
List of Tables
Summary Table: Global Market for Peptide Synthesis, by Peptide Type, Through 2028
Table 1: Pros and Cons of Liquid Phase and Solid Phase Synthesis
Table 2: Global Cancer Incidence
Table 3: Emerging Trends in Peptide Synthesis Technologies
Table 4: Global Market for Peptide Synthesis, by Peptide Type, Through 2028
Table 5: Global Market for Synthetic Type Peptides, by Region, Through 2028
Table 6: Global Market for Antimicrobial Type Peptides, by Region, Through 2028
Table 7: FDA-Approved Antimicrobial Peptide Drugs
Table 8: Global Market for Hormonal Peptides, by Region, Through 2028
Table 9: Global Market for Bioactive Peptides, by Region, Through 2028
Table 10: Global Market for Collagen Peptides, by Region, Through 2028
Table 11: Global Market for Other Peptides, by Region, Through 2028
Table 12: Global Market for Peptide Synthesis, by Application, Through 2028
Table 13: Global Market for Peptide Therapeutics, by Region, Through 2028
Table 14: Peptide-based Drugs Approved by FDA in 2021
Table 15: Best-Selling Peptide Therapeutics, 1982-2021
Table 16: Global Market for Cancer Applications in Peptide Therapeutics, by Region, Through 2028
Table 17: Approval of Peptide Agents Used for Cancer Therapy, 2019-2022
Table 18: Global Market for Diabetes Applications in Peptide Therapeutics, by Region, Through 2028
Table 19: Global Market for Neurology Applications in Peptide Therapeutics, by Region, Through 2028
Table 20: Global Market for Other Applications in Peptide Therapeutics, by Region, Through 2028
Table 21: Global Market for Cosmetics Applications in Peptide Synthesis, by Region, Through 2028
Table 22: Global Market for Nutraceutical Applications in Peptide Synthesis, by Region, Through 2028
Table 23: Global Market for Other Applications in Peptide Synthesis, by Region, Through 2028
Table 24: Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
Table 25: Global Market for Solid-phase Synthesis, by Region, Through 2028
Table 26: Global Market for Solution-phase Synthesis, by Region, Through 2028
Table 27: Global Market for Hybrid-phase Synthesis, by Region, Through 2028
Table 28: Global Market for Peptide Synthesis, by Region, Through 2028
Table 29: North American Market for Peptide Synthesis, by Country, Through 2028
Table 30: Protein Subunit Vaccines, in Clinical Phases, 2021-2022
Table 31: European Market for Peptide Synthesis, by Country, Through 2028
Table 32: Products and Services in Nordic Countries, 2020-2023
Table 33: Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
Table 34: Japanese Market Statistics
Table 35: RoW Market for Peptide Synthesis, by Country, Through 2028
Table 36: Role of ESG in Environmental Performance
Table 37: Role of ESG in Social Performance
Table 38: Role of ESG in Governance Performance
Table 39: ESG Rankings for Major Peptide Therapeutics Companies*
Table 40: Abbott: Company Snapshot
Table 41: Abbott: Financial Performance, FY 2022 and 2023
Table 42: Abbott: Product Portfolio
Table 43: Abbott: Recent Developments, 2022
Table 44: AbbVie Inc.: Company Snapshot
Table 45: AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 46: AbbVie Inc.: Product Portfolio
Table 47: AbbVie Inc.: Recent Developments, 2022
Table 48: Amgen Inc.: Company Snapshot
Table 49: Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50: Amgen Inc.: Product Portfolio
Table 51: Amgen Inc.: Recent Developments, 2023
Table 52: AstraZeneca: Company Snapshot
Table 53: AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54: AstraZeneca: Product Portfolio
Table 55: AstraZeneca: Recent Developments, 2024
Table 56: Boehringer Ingelheim International GmbH: Company Snapshot
Table 57: Boehringer Ingelheim International: Financial Performance, FY 2021 and 2022
Table 58: Boehringer Ingelheim International: Product Portfolio
Table 59: Boehringer Ingelheim International: Recent Developments, 2023
Table 60: Bristol Myers Squibb Co.: Company Snapshot
Table 61: Bristol Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 62: Bristol Myers Squibb Co.: Product Portfolio
Table 63: Bristol Myers Squibb Co.: Recent Developments, 2022
Table 64: B. Braun SE: Company Snapshot
Table 65: B. Braun SE: Financial Performance, FY 2021 and 2022
Table 66: B. Braun SE: Product Portfolio
Table 67: B. Braun SE: Recent Developments, 2022
Table 68: Lilly: Company Snapshot
Table 69: Lilly: Financial Performance, FY 2022 and 2023
Table 70: Lilly: Product Portfolio
Table 71: Lilly: Recent Developments, 2022
Table 72: Merck & Co. Inc.: Company Snapshot
Table 73: Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 74: Merck & Co. Inc.: Product Portfolio
Table 75: Merck & Co. Inc.: Recent Developments, 2021
Table 76: Moderna Inc.: Company Snapshot
Table 77: Moderna Inc.: Financial Performance, FY 2022 and 2023
Table 78: Moderna Inc.: Product Portfolio
Table 79: Moderna Inc.: Recent Developments, 2022
Table 80: Novartis AG: Company Snapshot
Table 81: Novartis AG: Financial Performance, FY 2022 and 2023
Table 82: Novartis AG: Product Portfolio
Table 83: Novartis AG: Recent Developments, 2023
Table 84: Novo Nordisk A/S: Company Snapshot
Table 85: Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
Table 86: Novo Nordisk A/S: Product Portfolio
Table 87: Novo Nordisk A/S: Recent Developments, 2024
Table 88: Sanofi: Company Snapshot
Table 89: Sanofi: Financial Performance, FY 2022 and 2023
Table 90: Sanofi: Product Portfolio
Table 91: Sanofi: Recent Developments, 2022
Table 92: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 93: Teva Pharmaceutical: Financial Performance, FY 2022 and 2023
Table 94: Teva Pharmaceutical: Product Portfolio
Table 95: Teva Pharmaceutical: Recent Developments, 2024
List of Figures
Summary Figure: Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 1: Trends in Peptide Therapeutics Manufacturing
Figure 2: Global Market for Peptide Synthesis: Market Dynamics
Figure 3: India’s Biotechnology Sectoral Thrust
Figure 4: Global Projected Incidence of Diabetes, Patients Age 20-79, 2010 and 2030
Figure 5: Global Infectious Disease Outbreaks, 2020 to 2022
Figure 6: Global Infectious Disease Outbreak, 2022
Figure 7: Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
Figure 8: Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 9: Global Market Shares of Peptide Synthesis, by Application, 2022
Figure 10: Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 11: Global Market Shares of Peptide Synthesis, by Region, 2022
Figure 12: North American Market Shares of Peptide Synthesis, by Application, 2022
Figure 13: North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 14: North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 15: North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 16: North American Market Shares of Peptide Synthesis, by Country, 2022
Figure 17: European Market Shares of Peptide Synthesis, by Application, 2022
Figure 18: European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 19: European Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 20: European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 21: European Market Shares of Peptide Synthesis, by Country, 2022
Figure 22: Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
Figure 23: Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 24: Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
Figure 25: Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 26: Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
Figure 27: RoW Market Shares of Peptide Synthesis, by Application, 2022
Figure 28: RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 29: RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
Figure 30: RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 31: RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
Figure 32: Leading Manufacturers’ Shares of the Global Market for Peptide Synthesis, 2022
Figure 33: Snapshot: Key ESG Trends in Peptide Therapeutics Industry
Figure 34: Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 35: Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 36: AbbVie Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 37: AbbVie Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 38: Amgen Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 39: Amgen Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 40: AstraZeneca: Revenue Shares, by Business Unit, FY 2023
Figure 41: AstraZeneca: Revenue Shares, by Country/Region, FY 2023
Figure 42: Boehringer Ingelheim International: Revenue Shares, by Business Unit, FY 2022
Figure 43: Boehringer Ingelheim International: Revenue Shares, by Country/Region, FY 2022
Figure 44: Bristol Myers Squibb Co.: Revenue Shares, by Business Unit, FY 2023
Figure 45: Bristol Myers Squibb Co.: Revenue Shares, by Country/Region, FY 2023
Figure 46: B. Braun SE: Revenue Shares, by Business Unit, FY 2022
Figure 47: B. Braun SE: Revenue Shares, by Country/Region, FY 2022
Figure 48: Lilly: Revenue Shares, by Business Unit, FY 2023
Figure 49: Lilly: Revenue Shares, by Country/Region, FY 2023
Figure 50: Merck & Co. Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51: Merck & Co. Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52: Moderna Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53: Novartis AG: Revenue Shares, by Business Unit, FY 2023
Figure 54: Novartis AG: Revenue Shares, by Country/Region, FY 2023
Figure 55: Novo Nordisk A/S: Revenue Shares, by Business Unit, FY 2023
Figure 56: Novo Nordisk A/S: Revenue Shares, by Country/Region, FY 2023
Figure 57: Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 58: Sanofi: Revenue Shares, by Country/Region, 2023
Figure 59: Teva Pharmaceutical: Revenue Shares by Business Unit, FY 2023
Figure 60: Teva Pharmaceutical: Revenue Shares, by Country/Region, FY 2023
